Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
40.39%
Price
18.12.25
€144.95
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. has seen massive gains of 40.39%. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -3.457% | -3.457% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat